Michele Park is a Venture Partner at NEA focusing on biopharma. She joined in 2021 and previously worked at Clarus Ventures, Credit Suisse, and Piper Jaffray.
At firms with a similar stage, sector and check size.
One email when Michele's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckMichele Park is a Venture Partner at NEA focusing on biopharma. She joined in 2021 and previously worked at Clarus Ventures, Credit Suisse, and Piper Jaffray.
Michele Park invests through New Enterprise Associates (NEA), which writes checks of $1M to $30M+ at pre-seed, seed, series a, series b.
A warm intro from a founder New Enterprise Associates (NEA) backed works best.
biotechnology research analyst at Piper Jaffray; biotechnology research analyst at Credit Suisse; investor at Clarus Ventures (now Blackstone Life Sciences); research analyst at Credit Suisse; research analyst at Piper Jaffray; Partner at Clarus Ventures.
Last updated 2026-10-15. Is this you? Ask for a correction.